FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...

Slit lamp photo of the ReStor IOL in the eye. (All images courtesy of Francesco Carones, MD.) BARCELONA – The apodized optic design of the pseudoaccomodative Alcon AcrySof ReStor IOL may overcome the ...

Please provide your email address to receive an email when new articles are posted on . MILAN — Alcon announced the launch of the AcrySof IQ ReSTOR +2.5 D and the AcrySof IQ ReSTOR multifocal toric +2 ...

Basel, Switzerland, April 16, 2015-Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof ® IQ ReSTOR ® ...

Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...

April 15, 2005 — The U.S. Food and Drug Administration (FDA) has approved a rechargeable neurostimulation system to aid in the management of chronic intractable pain of the trunk and/or limbs; a dural ...

The unique optical design of the ACTIVEFOCUS (TM) toric IOL gives astigmatic cataract patients quality distance vision and an increased range of vision to potentially reduce dependence on glasses The ...

US Food and Drug Administration (FDA) grants approval of the AcrySof ® IQ ReSTOR ® +2.5 Diopter (D) Intraocular Lens (IOL) for sale in the US Expands Alcon`s IOL portfolio for the correction of near, ...

Novartis International AG / Alcon receives US FDA approval for new AcrySof® IQ ReSTOR® +2.5 Multifocal Toric IOL with ACTIVEFOCUS design for uncompromised distance vision and presbyopia correction .